Transaction · 0001231589-26-000002

MAHON PAUL A

MAHON PAUL A, EVP, GC, reported an open-market or private sale at UNITED THERAPEUTICS Corp involving 40.000000 shares for an estimated $18989.60. Reported holdings after the transaction were 36781.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SEVP, GC
UTHRUNITED THERAPEUTICS Corp
Filing timeJan 15
Trade dateJan 15, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$471.99
Pre-filing
1mo ago +5.9%1w ago +4.0%1d ago +0.8%
Returns since
7d +0.0%30d +0.4%90d +22.4%180d +11.6%1y +9.8%

UTHR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
UTHR since 2026-01-15Filed 232 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001231589-26-000002
Common Stock
Transaction date
Jan 15, 2026
Filed Jan 15, 2026, 12:00 AM · 0d delay
Shares
40 sh
$47.4k per share
Estimated value
-$1.89M
Computed from shares × price
Holdings after
36.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & GENERAL COUNSEL

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $467.815 to $468.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to pro…

  3. F3

    This transaction was executed in multiple trades at prices ranging from $469.92 to $470.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  4. F4

    This transaction was executed in multiple trades at prices ranging from $472.13 to $472.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  5. F5

    This transaction was executed in multiple trades at prices ranging from $468.84 to $469.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

  6. F6

    This transaction was executed in multiple trades at prices ranging from $471.00 to $471.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to prov…

Original filing · 0001231589-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

UTHR